Literature DB >> 11949634

Myelodysplastic syndromes: from French-American-British to World Health Organization: a commentary.

John M Bennett, Richard D Brunning, James W Vardiman.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11949634     DOI： 10.1182/blood.v99.8.3074

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Significance of thrombocytopenia in myelodysplastic syndromes: associations and prognostic implications.

Authors:  Ali Al Ameri; Elias Jabbour; Guillermo Garcia-Manero; Susan O'Brien; Stefan Faderl; Farhad Ravandi; Jianqin Shan; Sherry Pierce; Jorge Cortes; Hagop Kantarjian
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-04-08

Review 2.  Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.

Authors:  R Tehranchi
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

Review 3.  Who is WHO in myelodysplastic syndromes? Clinical implications of the WHO classification.

Authors:  Rami S Komrokji; John M Bennett
Journal:  Curr Hematol Malig Rep       Date:  2006-03       Impact factor: 3.952

4.  Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes.

Authors:  Leonor Senent; Leonor Arenillas; Elisa Luño; Juan C Ruiz; Guillermo Sanz; Lourdes Florensa
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.